4.6 Article

Efficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation

Related references

Note: Only part of the references are listed.
Review Dermatology

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis

Kazuhisa Furue et al.

ACTA DERMATO-VENEREOLOGICA (2018)

Article Immunology

IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis

Charlie Bridgewood et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes

Anne Mueller et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Immunology

IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin

James J. Campbell et al.

JOURNAL OF IMMUNOLOGY (2017)

Review Dermatology

European consensus statement on phenotypes of pustular psoriasis

A. A. Navarini et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Genetics & Heredity

Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis

William R. Swindell et al.

GENOME MEDICINE (2017)

Review Immunology

Update on psoriasis immunopathogenesis and targeted immunotherapy

Satveer K. Mahil et al.

SEMINARS IN IMMUNOPATHOLOGY (2016)

Article Critical Care Medicine

CXCR2 Antagonist MK-7123 A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Stephen I. Rennard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Dermatology

Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1

Katelynn A. Milora et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Article Immunology

IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin

Alexander M. Foster et al.

JOURNAL OF IMMUNOLOGY (2014)

Article Dermatology

Autoinflammatory Pustular Neutrophilic Diseases

Haley B. Naik et al.

DERMATOLOGIC CLINICS (2013)

Review Biotechnology & Applied Microbiology

Biological therapies for psoriasis

Bobbak Mansouri et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2013)

Article Medicine, Research & Experimental

Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk

Luigi Tortola et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Dermatology

Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation

Amanda Robinson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)

Article Dermatology

Clinical and Laboratory Features in Acute Generalized Pustular Psoriasis A Retrospective Study of 34 Patients

Joao Borges-Costa et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)

Article Genetics & Heredity

Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis

Alexandros Onoufriadis et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2011)

Article Biochemistry & Molecular Biology

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

Jennifer E. Towne et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Medicine, General & Internal

Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

Slaheddine Marrakchi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Immunology

Overcoming hurdles in developing successful drugs targeting chemokine receptors

Thomas J. Schall et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Immunology

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

Leslie van der Fits et al.

JOURNAL OF IMMUNOLOGY (2009)